Personal Finance & Investing Information
Most Current NOVN news
Intelligent Investing News Intelligent Investing News Noven Therapeutics to acquire rights to Daytrana [AP] - Noven Pharmaceuticals Inc. said Tuesday that it has reached an agreement with Shire PLC to market and sell a patch for Attention Deficit and Hyperactivity Disorder. NOVEN PHARMACEUTICALS INC Files SEC form 8-K, Changes in Control or Registrant NOVEN PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Intelligent Investing News Intelligent Investing News
